Adverse Drug Reaction Classification System

Pharmaceutical Information
Drug Name Muromonab-cd3
Drug ID BADD_D01506
Description Murine monoclonal antibody specific to CD3 T-cell lymphocyte antigens. More specifically it is a purified murine (mouse) monoclonal antibody, directed against the CD3 (T3) receptor on the surface of human T-cells (T-lymphocytes) cultured using the murine ascites method. Muromonab is 93% monomeric immune globulin G type 2a (IgG2a).
Indications and Usage For treatment of organ transplant recipients, prevention of organ rejection
Marketing Status Not Available
ATC Code L04AA02
DrugBank ID DB00075
KEGG ID D05092
MeSH ID D016853
PubChem ID Not Available
TTD Drug ID D05GVQ
NDC Product Code Not Available
Synonyms Muromonab-CD3 | Muromonab CD3 | OKT3 | Monoclonal Antibody OKT3 | Orthoclone OKT3
Chemical Information
Molecular Formula Not Available
CAS Registry Number 140608-64-6
SMILES Not Available
Chemical Structure
ADR Related Proteins Induced by Drug
ADR Term Protein Name UniProt AC TTD Target ID PMID
Not AvailableNot AvailableNot AvailableNot AvailableNot Available
ADRs Induced by Drug
ADR Term ADReCS ID ADR Frequency (FAERS) ADR Severity Grade (FAERS) ADR Severity Grade (CTCAE)
Haemorrhage intracranial17.08.01.008; 24.07.04.003--
Hallucination19.10.02.002--
Headache17.14.01.001--
Hepatitis09.01.07.004--Not Available
Hepatomegaly09.01.05.001--Not Available
Herpes simplex23.09.03.001; 11.05.02.001--Not Available
Hyperhidrosis23.02.03.004; 08.01.03.028--
Hyperreflexia17.02.01.002--Not Available
Hypertension24.08.02.001--
Hyperventilation22.02.01.006; 19.01.02.004--Not Available
Hypotension24.06.03.002--
Hypotonia17.05.02.002; 15.05.04.008--Not Available
Hypoxia22.02.02.003--
Infection11.01.08.002--Not Available
Intestinal infarction24.04.08.008; 07.15.02.006--Not Available
Laryngospasm22.04.02.002--
Lethargy19.04.04.004; 17.02.04.003; 08.01.01.008--
Leukaemia01.10.03.001; 16.01.03.001--
Leukocytosis01.02.01.002--
Leukopenia01.02.02.001--Not Available
Lip swelling23.04.01.007; 10.01.05.005; 07.05.04.005--Not Available
Lymphadenopathy01.09.01.002--Not Available
Lymphoma16.20.01.001; 01.12.01.001--Not Available
Lymphopenia01.02.02.002--Not Available
Malaise08.01.01.003--
Meningitis17.06.03.001; 11.01.03.001--
Meningitis aseptic17.06.03.002; 11.01.03.002--Not Available
Microangiopathic haemolytic anaemia24.03.02.019; 01.06.02.002--Not Available
Mood altered19.04.02.007--Not Available
Myalgia15.05.02.001--
The 3th Page    First    Pre   3 4 5 6    Next   Last    Total 6 Pages